Difference between revisions of "Stop-agomelatine"
From Psychiatrienet
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Drugswitch | {{Drugswitch | ||
| from = agomelatine | | from = agomelatine | ||
| − | | stop = {{StopAgomelatine}} | + | | stop = {{StopAgomelatine}}<ref name="montgomery">{{RefMontgomery}}</ref>{{refBazire}} |
}} | }} | ||
Latest revision as of 07:55, 19 July 2011
| ||||||||||||||||||||||||||
Stop agomelatine
- ↑ McAllister-Williams RH et al. The use of antidepressants in clinical practice: focus on agomelatine. Hum Psychopharmacol. 2010 Mar 1;25(2):95-102
- ↑ Montgomery SA et al. Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. Int Clin Psychopharmacol. 2004 Sep;19(5):271-80
- ↑ Bazire S, Psychotropic Drug Directory 2010. Aberdeen: HealthComm UK Ltd; 2010.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
